Marghitoiu Liliana, Liu Jian, Lee Hans, Perez Lourdes, Fujimori Kiyoshi, Ronk Michael, Hammond Matthew R, Nunn Heather, Lower Asher, Rogers Gary, Nashed-Samuel Yasser
Drug Product Development, Amgen Inc., Thousand Oaks, CA;
Product Attribute Sciences, Amgen Inc., Thousand Oaks, CA;
PDA J Pharm Sci Technol. 2015 Jan-Feb;69(1):49-58. doi: 10.5731/pdajpst.2015.01001.
Studies of the extractable profiles of bioprocessing components have become an integral part of drug development efforts to minimize possible compromise in process performance, decrease in drug product quality, and potential safety risk to patients due to the possibility of small molecules leaching out from the components. In this study, an effective extraction solvent system was developed to evaluate the organic extractable profiles of single-use bioprocess equipment, which has been gaining increasing popularity in the biopharmaceutical industry because of the many advantages over the traditional stainless steel-based bioreactors and other fluid mixing and storage vessels. The chosen extraction conditions were intended to represent aggressive conditions relative to the application of single-use bags in biopharmaceutical manufacture, in which aqueous based systems are largely utilized. Those extraction conditions, along with a non-targeted analytical strategy, allowed for the generation and identification of an array of extractable compounds; a total of 53 organic compounds were identified from four types of commercially available single-use bags, the majority of which are degradation products of polymer additives. The success of this overall extractables analysis strategy was reflected partially by the effectiveness in the extraction and identification of a compound that was later found to be highly detrimental to mammalian cell growth.
The usage of single-use bioreactors has been increasing in biopharmaceutical industry because of the appealing advantages that it promises regarding to the cleaning, sterilization, operational flexibility, and so on, during manufacturing of biologics. However, compared to its conventional counterparts based mainly on stainless steel, single-use bioreactors are more susceptible to potential problems associated with compound leaching into the bioprocessing fluid. As a result, extractable profiling of the single-use system has become essential in the qualification of such systems for its use in drug manufacturing. The aim of this study is to evaluate the effectiveness of an extraction solvent system developed to study the extraction profile of single-use bioreactors in which aqueous-based systems are largely used. The results showed that with a non-targeted analytical approach, the extraction solvent allowed the generation and identification of an array of extractable compounds from four commercially available single-use bioreactors. Most of extractables are degradation products of polymer additives, among which was a compound that was later found to be highly detrimental to mammalian cell growth.
生物加工组件可提取物概况的研究已成为药物开发工作的一个组成部分,旨在尽量减少因小分子从组件中渗出而可能导致的工艺性能下降、药品质量降低以及对患者的潜在安全风险。在本研究中,开发了一种有效的萃取溶剂系统,以评估一次性生物加工设备的有机可提取物概况。由于相对于传统的不锈钢生物反应器和其他流体混合及储存容器具有诸多优势,一次性生物加工设备在生物制药行业越来越受欢迎。所选的萃取条件旨在模拟生物制药生产中一次性袋子使用时的严苛条件,其中大量使用水基系统。这些萃取条件与非靶向分析策略相结合,使得能够生成并鉴定一系列可提取物;从四种市售一次性袋子中总共鉴定出53种有机化合物,其中大多数是聚合物添加剂的降解产物。这种整体可提取物分析策略的成功部分体现在有效萃取和鉴定出一种后来被发现对哺乳动物细胞生长极为有害的化合物上。
由于一次性生物反应器在生物制品生产过程中的清洁、灭菌、操作灵活性等方面具有诱人优势,其在生物制药行业的使用一直在增加。然而,与主要基于不锈钢的传统生物反应器相比,一次性生物反应器更容易出现与化合物渗入生物加工流体相关的潜在问题。因此,一次性系统的可提取物分析对于此类系统在药物制造中的使用鉴定变得至关重要。本研究的目的是评估为研究大量使用水基系统的一次性生物反应器萃取概况而开发的萃取溶剂系统的有效性。结果表明,采用非靶向分析方法,该萃取溶剂能够从四种市售一次性生物反应器中生成并鉴定出一系列可提取物。大多数可提取物是聚合物添加剂的降解产物,其中一种化合物后来被发现对哺乳动物细胞生长极为有害。